North America
In North America preclinical CRO market is highly advanced, primarily driven by a strong biopharmaceutical sector and significant investment in R&D. The U.S. leads the region, where the demand for outsourced services is high due to the need for efficient drug development processes and specialized expertise. Key service areas include toxicology, pharmacology, and...
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Russian
Romaian